• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transforming properties of 8p11-12 amplified genes in human breast cancer.8p11-12 扩增基因在人乳腺癌中的转化特性。
Cancer Res. 2010 Nov 1;70(21):8487-97. doi: 10.1158/0008-5472.CAN-10-1013. Epub 2010 Oct 12.
2
PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.PPAPDC1B和WHSC1L1是8p11 - 12扩增子的常见驱动基因,不仅在乳腺肿瘤中如此,在胰腺腺癌和肺肿瘤中也是如此。
Am J Pathol. 2013 Nov;183(5):1634-1644. doi: 10.1016/j.ajpath.2013.07.028. Epub 2013 Sep 17.
3
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.复发性8p11 - 12扩增子的特征鉴定出磷酸酶蛋白PPAPDC1B作为乳腺癌的一个新治疗靶点。
Cancer Res. 2008 Sep 1;68(17):7165-75. doi: 10.1158/0008-5472.CAN-08-1360.
4
Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.具有8p11 - 12扩增子的人乳腺癌中LSM1癌基因的转化功能
Oncogene. 2007 Mar 29;26(14):2104-14. doi: 10.1038/sj.onc.1210002. Epub 2006 Sep 25.
5
A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.乳腺癌中位于8p11 - 12区域的一个1兆碱基的最小扩增子鉴定出了新的候选癌基因。
Oncogene. 2005 Aug 4;24(33):5235-45. doi: 10.1038/sj.onc.1208741.
6
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.人类乳腺癌8p11 - p12扩增子上的多个相互作用的致癌基因。
Cancer Res. 2006 Dec 15;66(24):11632-43. doi: 10.1158/0008-5472.CAN-06-2946.
7
Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.人乳腺癌细胞系中8p11 - 12扩增子的基因组及表达分析
Cancer Res. 2004 Jan 1;64(1):40-7. doi: 10.1158/0008-5472.can-03-1022.
8
Comprehensive profiling of 8p11-12 amplification in breast cancer.乳腺癌中8p11 - 12扩增的综合分析
Mol Cancer Res. 2005 Dec;3(12):655-67. doi: 10.1158/1541-7786.MCR-05-0128.
9
Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.乳腺肿瘤中位于8p12和11q13的共扩增基因在肿瘤发生过程中与两条主要通路协同作用。
Oncogene. 2009 Apr 30;28(17):1892-903. doi: 10.1038/onc.2009.34. Epub 2009 Mar 30.
10
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.WHSC1L1 的扩增调节 SUM-44 乳腺癌细胞中 ERα 的表达和雌激素非依赖性激活,并与乳腺癌中 ERα 的过表达相关。
Mol Oncol. 2016 Jun;10(6):850-65. doi: 10.1016/j.molonc.2016.02.003. Epub 2016 Feb 27.

引用本文的文献

1
Predicting fragment binding modes using customized Lennard-Jones potentials in short molecular dynamics simulations.在短分子动力学模拟中使用定制的 Lennard-Jones 势预测片段结合模式。
Comput Struct Biotechnol J. 2024 Dec 23;27:102-116. doi: 10.1016/j.csbj.2024.12.017. eCollection 2025.
2
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer.CRISPR/Cas9 介导的敲除策略增强乳腺癌的免疫治疗。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8561-8601. doi: 10.1007/s00210-024-03208-2. Epub 2024 Jun 22.
3
NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.NSD3 在癌症中的作用:揭示甲基转移酶依赖性和异构体特异性功能。
Int J Mol Sci. 2024 Jan 12;25(2):944. doi: 10.3390/ijms25020944.
4
Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.单细胞测序分析与鞘脂代谢相关,指导皮肤黑色素瘤的免疫治疗和预后。
Front Immunol. 2023 Nov 23;14:1304466. doi: 10.3389/fimmu.2023.1304466. eCollection 2023.
5
KCNN1 promotes proliferation and metastasis of breast cancer via ERLIN2-mediated stabilization and K63-dependent ubiquitination of Cyclin B1.KCNN1 通过 ERLIN2 介导的 Cyclin B1 稳定化和 K63 依赖性泛素化促进乳腺癌的增殖和转移。
Carcinogenesis. 2023 Dec 30;44(12):809-823. doi: 10.1093/carcin/bgad070.
6
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2).靶向核受体结合 SET 域蛋白 2(NSD2)的药物发现。
J Med Chem. 2023 Aug 24;66(16):10991-11026. doi: 10.1021/acs.jmedchem.3c00948. Epub 2023 Aug 14.
7
Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.了解 NSD 蛋白甲基转移酶在头颈部鳞状细胞癌中的作用。
Genes (Basel). 2022 Nov 2;13(11):2013. doi: 10.3390/genes13112013.
8
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.NSD1、NSD2 和 NSD3 组蛋白甲基转移酶在实体瘤中的作用。
Cell Mol Life Sci. 2022 May 9;79(6):285. doi: 10.1007/s00018-022-04321-2.
9
Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma.类Sm基因家族在早期胰腺导管腺癌中的预后价值及潜在分子机制
Transl Cancer Res. 2021 Apr;10(4):1744-1760. doi: 10.21037/tcr-20-3056.
10
Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer.LSM家族基因在乳腺癌中的潜在治疗和预后价值
Cancers (Basel). 2021 Sep 29;13(19):4902. doi: 10.3390/cancers13194902.

本文引用的文献

1
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.FGFR1 扩增导致内分泌治疗耐药,是乳腺癌的治疗靶点。
Cancer Res. 2010 Mar 1;70(5):2085-94. doi: 10.1158/0008-5472.CAN-09-3746. Epub 2010 Feb 23.
2
The landscape of somatic copy-number alteration across human cancers.人类癌症中体细胞拷贝数改变的全景。
Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.
3
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.SOX2是肺和食管鳞状细胞癌中一种扩增的谱系存活癌基因。
Nat Genet. 2009 Nov;41(11):1238-42. doi: 10.1038/ng.465. Epub 2009 Oct 4.
4
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.可变剪接调控机制:来自分子和基因组学方法的见解
Nat Rev Mol Cell Biol. 2009 Nov;10(11):741-54. doi: 10.1038/nrm2777. Epub 2009 Sep 23.
5
RCP is a human breast cancer-promoting gene with Ras-activating function.RCP是一种具有Ras激活功能的人类乳腺癌促进基因。
J Clin Invest. 2009 Aug;119(8):2171-83. doi: 10.1172/JCI37622. Epub 2009 Jul 20.
6
Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.伴有8p11 - 12扩增的SFRP1甲基化相关沉默抑制乳腺癌中的经典和非经典WNT信号通路。
Int J Cancer. 2009 Oct 1;125(7):1613-21. doi: 10.1002/ijc.24518.
7
A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.通过454深度测序绘制的原发性人类乳腺癌转录图谱。
BMC Genomics. 2009 Apr 20;10:163. doi: 10.1186/1471-2164-10-163.
8
Regulation of Set9-mediated H4K20 methylation by a PWWP domain protein.一个含PWWP结构域蛋白对Set9介导的H4K20甲基化的调控
Mol Cell. 2009 Feb 27;33(4):428-37. doi: 10.1016/j.molcel.2009.02.002.
9
TGFBI deficiency predisposes mice to spontaneous tumor development.转化生长因子β诱导蛋白(TGFBI)缺乏使小鼠易发生自发性肿瘤。
Cancer Res. 2009 Jan 1;69(1):37-44. doi: 10.1158/0008-5472.CAN-08-1648.
10
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.复发性8p11 - 12扩增子的特征鉴定出磷酸酶蛋白PPAPDC1B作为乳腺癌的一个新治疗靶点。
Cancer Res. 2008 Sep 1;68(17):7165-75. doi: 10.1158/0008-5472.CAN-08-1360.

8p11-12 扩增基因在人乳腺癌中的转化特性。

Transforming properties of 8p11-12 amplified genes in human breast cancer.

机构信息

Breast Cancer Program and Systems and Computational Biology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

Cancer Res. 2010 Nov 1;70(21):8487-97. doi: 10.1158/0008-5472.CAN-10-1013. Epub 2010 Oct 12.

DOI:10.1158/0008-5472.CAN-10-1013
PMID:20940404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3089754/
Abstract

Amplification of the 8p11-12 region has been found in about 15% of human breast cancers and is associated with poor prognosis. Earlier, we used genomic analysis of copy number and gene expression to perform a detailed analysis of the 8p11-12 amplicon to identify candidate oncogenes in breast cancer. We identified 21 candidate genes and provided evidence that three genes, namely, LSM-1, TC-1, and BAG4, have transforming properties when overexpressed. In the present study, we systematically investigated the transforming properties of 13 newly identified 8p11-12 candidate oncogenes in vitro. WHSC1L1, DDHD2, and ERLIN2 were most potently transforming oncogenes based on the number of altered phenotypes expressed by the cells. WHSC1L1 contains a PWWP-domain that is a methyl-lysine recognition motif involved in histone code modification and epigenetic regulation of gene expression. Knockdown of WHSC1L1 in 8p11-12-amplified breast cancer cells resulted in profound loss of growth and survival of these cells. Further, we identified several WHSC1L1 target genes, one of which is iroquois homeobox 3 gene (IRX3), a member of the Iroquois homeobox transcription factor family.

摘要

8p11-12 区域的扩增在约 15%的人类乳腺癌中被发现,与预后不良有关。早些时候,我们使用拷贝数和基因表达的基因组分析对 8p11-12 扩增子进行了详细分析,以鉴定乳腺癌中的候选癌基因。我们确定了 21 个候选基因,并提供了证据表明,当过度表达时,三个基因,即 LSM-1、TC-1 和 BAG4,具有转化特性。在本研究中,我们系统地研究了 13 个新鉴定的 8p11-12 候选癌基因在体外的转化特性。基于细胞表达的改变表型的数量,WHSC1L1、DDHD2 和 ERLIN2 是最有效的转化致癌基因。WHSC1L1 含有一个 PWWP 结构域,这是一个参与组蛋白编码修饰和基因表达的表观遗传调控的甲基赖氨酸识别基序。在 8p11-12 扩增的乳腺癌细胞中敲低 WHSC1L1 导致这些细胞的生长和存活明显丧失。此外,我们鉴定了几个 WHSC1L1 的靶基因,其中一个是同源框基因 3(IRX3),它是同源盒转录因子家族的一员。